Skip Navigation



Carcinogenesis Advance Access published online on July 14, 2008

Carcinogenesis, doi:10.1093/carcin/bgn162
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
29/9/1807    most recent
bgn162v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lin, C.-W.
Right arrow Articles by Chen, Y.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, C.-W.
Right arrow Articles by Chen, Y.-C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Quercetin inhibition of tumor invasion via suppressing PKC{delta}/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells

Cheng-Wei Lina, Wen-Chi Houb, Shing-Chuan Shenc, Shu-Hui Juanc, Ching-Huai Kod, Ling-Mei Wangd and Yen-Chou Chenc,e,*

a Graduate Institute of Pharmacy, School of Pharmacy, Taipei Medical University, Taipei, Taiwan
b Graduate Institute of Pharmacognosy, School of Pharmacy, Taipei Medical University, Taipei, Taiwan
c Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan
d Cell Engineering Lab, Biomedical Engineering Research Laboratories, The Industrial Technology Research Institute, Hsing-Chu, Taiwan
e Cancer Research Center and Orthopedics Research Center, Taipei Medical University Hospital, Taipei, Taiwan

* Corresponding author: Dr. Yen-Chou Chen, Tel: 886-2-27361661 ext. 3421. Fax: 886-2-23787139. E-mail: yc3270{at}tmu.edu.tw (Y.C. Chen)

Quercetin (3,5,7,3',4'-tetrahydroxyflavone; QUE) has been shown to possess several beneficial biological activities including anti-tumor, anti-inflammation, and antioxidant properties; however, the effects of QUE in preventing invasion by breast carcinoma cells are still undefined. Increases in the protein, mRNA, and enzyme activity levels of matrix metalloproteinase-9 (MMP-9) were observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated MCF-7 cells, and these were blocked by QUE, but not by quercitrin (QUI) or rutin (RUT). A translocation of protein kinase C (PKC){delta} from the cytosol to the membrane followed by activation of ERK and c-Jun/AP-1 by TPA was demonstrated, and TPA-induced MMP-9 activation and migration were inhibited by the pan PKC inhibitor, GF109203X (GF), the specific PKC{delta} inhibitor, rottlerin (Rot), an ERK inhibitor (PD98059), and an AP-1 inhibitor (curcumin). Application of QUE significantly suppressed TPA-induced activation of the PKC{delta}/ERK/AP-1 signaling cascade. To elucidate the importance of OH substitutions to QUE's inhibition of tumor migration, several structurally related flavones of QUE including 3',4'-diOH, 3',4'-diOCH3, 3,5,7-triOH, 3,4',4'-triOH, 3,3',4'-triOCH3, luteolin, and fisetin were used. Results suggested that OH groups at both C3' and C4' play central roles in QUE's inhibition of TPA-induced MMP-9 activation and migration, and an additional OH at C3, C5, or C7 may increase the inhibitory potency of the 3',4'-diOH flavone against TPA-induced MMP-9 activity and migration. The anti-tumor invasion and migration effects of breast carcinoma cells induced by QUE with the structure-activity relationship analysis were identified.

Key Words: Quercetin • Flavonoids • Invasion • MMP-9 • Breast cancer

Received April 2, 2008; revised June 19, 2008; accepted July 5, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.